Tagged / collaboration

IMSET Seminar: Understanding coastal change

Thursday 18 March at 4pm 

Understanding coastal change: impact and implications global to local scales with Dr Sally Brown, Bournemouth University  

Coastal zones are under multiple threats of natural and anthropogenic change. The impact of these threats are anticipated to worsen with climate change and the effects of sea-level rise. In this presentation, Sally will highlight different elements of her research, including how physical processes and socio-economic change vary throughout time, and demonstrate methods and solutions to adapt to these changes. Examples will be taken from global, regional and local scales from areas that Sally has worked on around the world. 

Sally is a coastal and climate change adaptation scientist. She joined BU in 2018, and as all but six weeks of her time at BU has been part-time or working from home, she is keen to integrate more and work with others in research at BU. Find out more about Sally’s research.  

The curious start of an academic collaboration

The curious start of an academic collaboration

Two days ago a group of academic from Bournemouth University (BU) submitted a bid for a research grant to the NIHR (National Institute for Health Research) to help prevent the drowning of toddlers in Bangladesh.  The proposed research is a collaboration with the RNLI (Royal National Lifeboat Institution), and an other UK university, the University of the West of England (UWE) and a research organisation called CIPRB (Centre for Injury Prevention and Research, Bangladesh).   Nothing particularly out of the ordinary there.  BU academics submit collaborative bid for research grants all the time, with colleagues at other universities, with large charities (like the RNLI), and with research institutes across the globe.  What I find intriguing is the round-about way this particular collaboration came about within BU.

The NIHR called for research proposals in reply to its Global Health Transformation (RIGHT) programme.  The RNLI approached CIPRB, an expert in accident prevention from UWE and BU experts in health economics and human-centred design to discuss putting in an intention to bid.  The RNLI has a history of working with both CIPRB in Bangladesh on drowning prevention and with BU in various design project (including improved ball bearings for launching lifeboats).  The team decided that it needed a sociologist to help study the social and cultural barriers to the introduction of interventions to prevent drowning in very young toddlers (12-14 months).  My name was mentioned by our UWE colleague whom I know from her work in Nepal.  For example, she and I had spoken at the same trauma conference in Nepal and the lead researcher on her most recent project is one of my former students.

Thus, I was introduced to my BU colleagues in different departments (and faculties) by an outsider from a university miles away.  I think it is also interesting that after twelve years at BU I am introduced to fellow researchers at the RNLI, especially since I only need to step out of my house and walk less than five minutes to see the RNLI headquarters in Poole.

Prof. Edwin van Teijlingen

CMMPH (Centre for Midwifery, Maternal & Perinatal Health)

 

Clinical Governance RKEDF sessions

As part of the RKEDF Academics and Researchers can book onto the following sessions, either as a one-to-one meeting or a bespoke team session:

Please contact Suzy Wignall, Clinical Governance Advisor if you are interested in any of these sessions.

HEIF Small Fund Reminder: First Application Round Closes Wednesday 17 March

The first round for applications closes on Wednesday 17 March.

Bournemouth University has a small amount of funding available to facilitate and enhance research and development collaboration with external partners.

The purpose of the funding is to:

  • Enhance external collaborative engagements with industry partners to further the development of innovative projects
  • Increase the amount of available funds for research undertaken collaboratively with external partners to patent innovations, enhance technology readiness levels and/or commercialisation
  • Encourage future funding bids (such as from Innovate UK) with external partners

There is flexibility in the way that the fund can be used, provided that a strong case can be made, and the assessment criteria are met. Funding could be used in various ways, for example for consumables, staff, and for travel/events/meetings, where restrictions allow.

All funding will need to be spent by 31 July 2021.

Eligibility/What we can fund

The HEIF Small Fund is open to all researchers across Bournemouth University, including those who are already working with industry partners and those who would like to build up new networks. In particular, the panel would welcome the following types of applications:

  • Projects of up to £5,000 which will either facilitate new relationships with external partners or build on existing research collaborations with external partners, support initial prototyping, project/product feasibility and/or market research.
  • Subject to the lifting of current restrictions, small travel grants of up to £500 to help facilitate relationship development with organisations. This could be travelling to potential partner sites or networking/funding briefing events Please note, the HEIF Funding Panel will not fund applications relating to conferences.

Due to the nature of this fund, we particularly welcome applications;

  • from Early Career Researchers (ECRs)
  • that incorporate social sciences and humanities
  • that demonstrate research interdisciplinarity

In line with BU2025, we will positively encourage applications from under-represented groups.

Application process

To apply, please read the guidance and complete the application form

Applications must be submitted to heif@bournemouth.ac.uk

Applications will be reviewed by the HEIF Funding Panel (see Panel Information below), with recommendations submitted to the Research Performance and Management Committee (RPMC) monthly. Once a decision has been made, this will be communicated to applicants. We aim to confirm the outcomes within two to three weeks of the closing date for that month.

The closing dates for each monthly assessment are as follows:

  • Wednesday 17 March
  • Wednesday 14 April
  • Wednesday 12 May
  • Wednesday 16 June

BU’s Funding Panels and Research Principles

The following funding panels operate to prioritise applications for funding and make recommendations to the Research Performance and Management Committee (RPMC).

There are eight funding panels:

  1. HEIF Funding Panel
  2. GCRF Funding Panel
  3. Research Impact Funding Panel
  4. Doctoral Studentship Funding Panel
  5. ACORN Funding Panel
  6. Research Fellowships Funding Panel
  7. Charity Impact Funding Panel
  8. SIA Funding panel

These panels align with the BU2025 focus on research, including BU’s Research Principles

The following BU2025 Principles are most relevant to the HEIF Panel:

  • Principle 1 – which recognises the need to develop teams
  • Principle 5 – which sets of the context for such funding panels

If you have any questions please email heif@bournemouth.ac.uk

Two new COVID-19 papers in FHSS

Today FHSS Prof. Jonathan Parker published an article (online first) on structural discrimination and abuse associated with COVID-19 in care homes in The Journal of Adult Protection [1].  Whilst Dr. Preeti Mahato, Prof. Edwin van Teijlingen and FHSS Visiting Professor Padam Simkhada had a COVID-19 paper published in the Journal of Midwifery Association of Nepal (JMAN) in late-January 2021 [2], although an electronic copy only reached their email inbox today.

 

  1. Parker, J. (2021) Structural discrimination and abuse: COVID-19 and people in care homes in England and Wales, The Journal of Adult Protection, Online ahead-of-print. https://doi.org/10.1108/JAP-12-2020-0050
  2. Tamang, P., Mahato, P., Simkhada P., Bissell, P., van Teijlingen, E. (2021) Pregnancy, Childbirth, Breastfeeding and Coronavirus Disease: What is known so far? Journal of Midwifery Association of Nepal (JMAN) 2(1): 96-101.

High Resolution 3D Digital Assets of Whole body Human Anatomy available for BU Research and Education

As one of the products from the HEIF6 Project, our team has developed a wide collection of digital assets to represent human anatomy. The understanding of human anatomy is vital to the delivery of healthcare. For medical students, this necessary awareness of anatomy and 3D spatial orientation is traditionally learned through cadaveric dissection. This is expensive and has practical as well as ethical constraints to available teaching time. The digital models can be used as assets for interdisciplinary research between the fields of Arts, Science and Healthcare. We welcome ideas from the BU community for proposals of novel use cases, research, grant applications and availability as teaching tools or base models for complex animation techniques.

Contact:

Learn more about the available assets and how to collaborate with the Neuravatar team by contacting Dr Xiaosong Yang (xyang@bournemouth.ac.uk) or Dr. Rupert Page (Rupert.Page@poole.nhs.uk).

👀 A glance at the 3D models available so far 👀

 

NIHR issues final update on implementation of the Restart Framework

The NIHR published a Framework on 21 May 2020 – when the NHS started to restore routine clinical services – to support the restarting of research paused due to COVID-19. Developed in partnership with multiple stakeholders and the devolved nations, the Framework provides a flexible structure for local decision-making.

You can read the latest and final update here.

Integrated Research Application System (IRAS) – survey open

IRAS, the Integrated Research Application System, is changing.

The Health Research Authority wants to hear from people who’ve used the system about how it should look in the future.

A short anonymous survey https://www.surveymonkey.co.uk/r/5B5X95H is available until 24th February 2021.

IMSET Seminar – Human adaptation and coastal evolution in northern Vietnam

IMSET is delighted to invite you to the second of our 2021 seminar series on long-term human ecodynamics, to be given by Dr. Ryan Rabett (Queen’s University Belfast) on:

“Human adaptation & coastal evolution in northern Vietnam: an overview of outcomes & spin-outs”

Thursday February 18th 16:00 – 17:00

Dr Rabett is a senior lecturer in human palaeoecology and his research interests include early human adaptation and dispersal, as well as biodiversity and conservation. He currently leads research projects in several parts of the world, including Southeast Asia.

IMSET is the BU Institute for Modelling Socio-Environmental Transitions.

Find out more and book your place:

https://www.eventbrite.co.uk/e/140049388491

Congratulations to Prof. Jonathan Parker

Congratulations to Professor Jonathan Parker on his latest publication ‘By Dint of History: Ways in which social work is (re)defined by historical and social events‘.  This interesting paper is co-authored with Magnus Frampton from the Universität Vechta in Germany and published in the international journal Social Work & Society.

 

Reference:

  1.  Parker, J., Frampton, M. (2020) By Dint of History: Ways in which social work is (re)defined by historical and social events, Social Work & Society, Volume 18, Issue 3: 1-17.

 

 

Invitation to VIRTUAL STEAMlab

On Wednesday, 24 February 2021, BU’s Research, Support & Development Office will be hosting our very first, pilot Virtual STEAMlab (Science/Tech/Engineering/Arts/Maths lab) event under the aegis of the strategic investment area (SIA) of Animation, Simulation & Visualisation (ASV). It will also be the first of a series of 2-hour long virtual ASV STEAMlabs to be held in the course of 2021.

This first STEAMlab will introduce and address four core priority areas for the strategic development of ASV cross-faculty, multi-disciplinary collaborations across BU in conjunction with external partners. These 4 areas are:

Virtual Production

Digital Health

Environment in Crisis

Virtual Heritage

This first STEAMlab will focus on these ASV themes in break-out rooms to target specific funding opportunities.

The ideas generated at this event may also be used to help select colleagues for Scramble events at short notice.

Booking onto this event

To take part in this exciting opportunity, all participants should complete the ASV Virtual STEAMLab Application Form V2 and return this to Nicolette Barsdorf-Liebchen at nbliebchen@bournemouth.ac.uk by Friday, 5 February 2021.

By applying, you agree to attend for the full duration of the event on 24 February 2021, 1 – 3 pm. Places are strictly limited and you will be contacted to confirm your “virtual space” by 12 February 2021.

If you have any queries prior to submitting your application, please contact Nicolette Barsdorf-Liebchen.

 

The Brief

We’re seeking to come up with highly innovative and urgently required research which is ambitious in scope and will require a high level of expertise, commitment and funding. The research must address challenges in the above-mentioned areas, and seek to deploy BU’s considerable ASV expertise and assets.

In short, we anticipate the development of innovative, ground-breaking and ambitious projects which have the capacity to attract significant, high value funding from the public and private sectors.

Who should attend?

We welcome those who wish to contribute to having a positive impact through addressing these challenges, but in particular, we are specifically targeting the following:

  1. Those academics whose research aligns with one or more of these core areas, or whose research would benefit from the multidisciplinary, collaborative engagement supported by the ASV SIA;
  2. Who has experience of involvement in medium to large research projects, and finally;
  3. Who either has the capacity to lead as PI on ideas arising from the STEAMlab in a working group towards development of a substantial grant application of close to or above £1 million, or has the ambition, research track record and commitment to be involved in the same.

We will also be inviting relevant external attendees, such as digital technology companies, to contribute on the day.

Some Answers to your FAQs:

Do I need to do anything in advance?

No, you do not. During the STEAMLab, you’ll be guided through a process which results in the development of research ideas. The process facilitates creativity, potentially leading to grand, innovative and interdisciplinary research ideas. These ideas will be explored with other attendees, and further developed based on the feedback received.

 

What is the immediate objective?

The objective by the end of the STEAMlab is to have scoped some leading and grand ideas around which a working group or cluster can be formed to take forward towards the development of a large grant application.

What do I need to do afterwards?

Your project idea may be “oven-ready”, but it is more likely than not that, given the level of pioneering innovation sought, you/your group’s project idea/s will require some time to crystallise fully, and for the optimum partners to be found for the bidding consortium, and bringing to fruition a fully-fledged grant application. To this end, it is envisaged that you and your potential collaborators will be committed to meeting on a regular basis, with a firm timetable. Substantial administrative support will be available from both RDS as a whole and the ASV Research Facilitator, Dr Nicolette Barsdorf-Liebchen, to advance your project development and manage working groups.

What if my topic area is very specialised, within fields such as medical diagnostics or environmental science?

Your contribution will be very welcome! One of the main benefits of a STEAMlab event is to bring together individuals with a range of backgrounds and specialisms who are able to see things just that bit differently to one another.

New publication Dr. Orlanda Harvey

Congratulations to Social Work Lecturer Dr. Orlanda Harvey on the acceptance of a paper by the journal Drugs: Education, Prevention & Policy. This latest academic paper ‘Libido as a motivator for starting and restarting non-prescribed anabolic androgenic steroid use among men: a mixed-methods study’ [1] is based on her Ph.D. research.  Previous papers associated with her thesis covered aspects of non-prescribed anabolic androgenic steroid use [2-3] as well as her wider Ph.D. journey [4].

 

References:

    1. Harvey, O., Parrish, M., van Teijlingen, E, Trenoweth, S. (2021) Libido as a reason to use non-prescribed Anabolic Androgenic Steroids, Drugs: Education, Prevention & Policy (accepted).
    2. Harvey, O., Keen, S., Parrish, M., van Teijlingen, E. (2019) Support for people who use Anabolic Androgenic Steroids: A Systematic Literature Review into what they want and what they access. BMC Public Health 19: 1024 https://doi.org/10.1186/s12889-019-7288-x https://rdcu.be/bMFon
    3. Harvey, O., Parrish, M., van Teijlingen, E., Trenoweth, S. (2020) Support for non-prescribed Anabolic Androgenic Steroids users: A qualitative exploration of their needs Drugs: Education, Prevention & Policy 27:5, 377-386. doi 10.1080/09687637.2019.1705763
    4. Spacey, A., Harvey, O., Casey, C. (2020) Postgraduate researchers’ experiences of accessing participants via gatekeepers: ‘wading through treacle!’  Journal of Further and Higher Education 2: 1-18.

 

Department of Health and Social Care statement on prioritisation of research studies

Please find below a statement from the Department of Health & Social Care. Please bear this in mind when in correspondence with NHS Trusts and if planning a clinical research study.
If you have any queries, please contact Suzy Wignall, Clinical Governance Advisor, in the first instance.


Statement from DHSC 

We recognise that at the current time those working in many NHS sites are under huge pressure as the number of COVID-19 cases and admissions to hospitals continue to rise and frontline clinical staff are unable to work due to sickness.

While we have a small number of proven treatments and vaccines for COVID-19, more are needed to reduce transmission, reduce the number of patients that require hospitalisation and to improve outcomes for those that do. It is therefore critical that at this challenging time we continue to recruit participants to our urgent public health (UPH) studies. As such I am writing to confirm that the current levels of prioritisation for research studies, set out within the Restart Framework still apply, as follows:

  • Level 1a (Top Priority) – COVID-19 UPH vaccine and prophylactic studies (as prioritised by the Vaccines Task Force and agreed by Jonathan Van-Tam, deputy CMO) and platform therapeutics trials (currently RECOVERY/RECOVERY +; PRINCIPLE; REMAP CAP).
  • Level 1b – Other COVID-19 UPH studies
  • Level 2 – Studies where the research protocol includes an urgent treatment or intervention without which patients could come to harm. These might be studies that provide access to potentially life preserving or life-extending treatment not otherwise available to the patient.
  • Level 3 – All other studies (including COVID-19 studies not in Level 1a or 1b).

I would also like to take this opportunity to remind you of the NIHR guidance for a second wave of covid 19 activity (https://www.nihr.ac.uk/documents/nihr-guidance-for-a-second-wave-of-covid-19-activity/25837).This guidance still applies and, as outlined, states that the deployment of staff funded through an NIHR Infrastructure award or funded by the NIHR Clinical Research Network (CRN) to front line duties should only occur in exceptional circumstances.

The deployment of clinical academic staff should be undertaken within the guidelines issued by a working group convened by the UK Clinical Academic Training Forum and the Conference of Postgraduate Medical  Deans of the UK. Where NHS Trusts consider they need to redeploy staff to support the frontline this should only be done to support clinical activity during the emergency phase of the pandemic and we would expect them to return to their R&D roles as soon as possible, once the pressures on the system reduce.

As indicated by the Restart Framework, at the current time, we need to continue prioritise our support for the most urgent COVID-19 research as part of the response to tackle the pandemic. At the same time we need to ensure we continue to try and maintain support to deliver non-COVID studies currently open on the portfolio, particularly those within Level 2. A system-wide Recovery, Resilience and Growth programme has been established which brings together the key partners across the clinical research ecosystem to ensure the UK is well-positioned to take a coordinated national approach to achieving the recovery of the UK’s clinical research delivery and restore a full, diverse and active research portfolio as soon as practicable.

COVID-19 in Qatar

Peer reviewing is the backbone of academic publishing. It is this peer review process to ensure that papers/publications have been vetted scientifically prior to publication by experts in the field, i.e. one’s peers. However, the process is not without its problems. One such problems is the delay in academic publishing. For example, a few days ago we published a substantive editorial on COVID-19 in Qater [1].  When we submitted this in July 2020 the information in our editorial was very up to date, and it still was when the Qatar Medical Journal accepted it on 26th July 2020.  Unfortunately, with all the incredibly rapid developments in vaccine development, approval and roll out some of the paper now reads like ‘historial data’.

 

Prof. Edwin van Teijlingen

Centre for Midwifery, Maternal & Perinatal Health (CMMPH)

 

Reference:

  1. van Teijlingen, E.R., Sathian, B., Simkhada, P., Banerjee, I. (2021) COVID-19 in Qatar: Ways forward in public health & treatment, Qatar Medical Journal 2020(38): 1-8 https://doi.org/10.5339/qmj.2020.38